132 related articles for article (PubMed ID: 29940648)
21. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
Armstrong LTD; Magnusson MR; Guppy MPB
J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1738-1745. PubMed ID: 28579037
[TBL] [Abstract][Full Text] [Related]
22. Metatypical basal cell carcinoma: from the primary tumour to a generalized metastatic process - description of diagnostics and combination therapy of an extremely rare skin cancer.
Madej-Czerwonka B; Korga-Plewko A
Ann Agric Environ Med; 2022 Mar; 29(1):152-156. PubMed ID: 35352920
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis, treatment and follow-up control in 124 patients with basal cell carcinoma of the maxillofacial region treated from 1992 to 1997.
Friedrich RE; Giese M; Li L; Schenk Y; Schmelzle R
Anticancer Res; 2005; 25(3A):1693-7. PubMed ID: 16033084
[TBL] [Abstract][Full Text] [Related]
24. [Trichoblastoma and superficial basal cell carcinoma arising in naevus sebaceous].
Gouillon L; Thomas L; Dalle S
Ann Dermatol Venereol; 2017 Feb; 144(2):154-155. PubMed ID: 27751525
[No Abstract] [Full Text] [Related]
25. Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal.
Webb DV; Mentrikoski MJ; Verduin L; Brill LB; Wick MR
Ann Diagn Pathol; 2015 Apr; 19(2):70-5. PubMed ID: 25702956
[TBL] [Abstract][Full Text] [Related]
26. Difficult to diagnose skin cancer--the 'aggressive' BCC.
Tomas S
Aust Fam Physician; 2009 Jul; 38(7):492-7. PubMed ID: 19575067
[TBL] [Abstract][Full Text] [Related]
27. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.
Bartoš V; Pokorný D; Zacharová O; Haluska P; Doboszová J; Kullová M; Adamicová K; Péč M; Péč J
Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):67-75. PubMed ID: 21993704
[TBL] [Abstract][Full Text] [Related]
28. Basal cell carcinoma and basosquamous carcinoma, two faces of the same condition?
Urechescu HC; Balica NC; Sarău CA; Anghelina F; Horhat ID; Baderca F; Jifcu EM; Ştefănescu EH; Poenaru M; Pricop MO
Rom J Morphol Embryol; 2018; 59(3):989-996. PubMed ID: 30534845
[TBL] [Abstract][Full Text] [Related]
29. Development of squamous cell carcinoma into basal cell carcinoma under treatment with Vismodegib.
Saintes C; Saint-Jean M; Brocard A; Peuvrel L; Renaut JJ; Khammari A; Quéreux G; Dréno B
J Eur Acad Dermatol Venereol; 2015 May; 29(5):1006-9. PubMed ID: 24980899
[TBL] [Abstract][Full Text] [Related]
30. Metatypical Basal cell carcinomas: a successful surgical approach to two cases with different tumor locations.
Tchernev G; Ananiev J; Cardoso JC; Wollina U
Maedica (Bucur); 2014 Mar; 9(1):79-82. PubMed ID: 25553132
[TBL] [Abstract][Full Text] [Related]
31. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
[TBL] [Abstract][Full Text] [Related]
32. Management of periorbital basal cell carcinoma with orbital invasion.
Sun MT; Wu A; Figueira E; Huilgol S; Selva D
Future Oncol; 2015 Nov; 11(22):3003-10. PubMed ID: 26437207
[TBL] [Abstract][Full Text] [Related]
33. [Basal cell carcinoma].
Debarbieux S; Harou O; Thomas L;
Ann Dermatol Venereol; 2013 Nov; 140(11):725-7. PubMed ID: 24206812
[No Abstract] [Full Text] [Related]
34. Expression of CXCR4, MMP-13 and β-catenin in different histological subtypes of facial basal cell carcinoma.
Ciurea ME; Cernea D; Georgescu CC; Cotoi OS; Pătraşcu V; Pârvănescu H; Popa D; Pârvănescu V; Ciurea RN; Mercuţ R
Rom J Morphol Embryol; 2013; 54(4):939-51. PubMed ID: 24398989
[TBL] [Abstract][Full Text] [Related]
35. Basal cell carcinoma presenting as a large pore.
Benedetto AV; Benedetto EA; Griffin TD
J Am Acad Dermatol; 2002 Nov; 47(5):727-32. PubMed ID: 12399765
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma.
Cheretis C; Angelidou E; Dietrich F; Politi E; Kiaris H; Koutselini H
Med Sci Monit; 2008 May; 14(5):MT13-19. PubMed ID: 18443558
[TBL] [Abstract][Full Text] [Related]
37. Clinical and pathologic parameters predicting recurrence of facial basal cell carcinoma: a retrospective audit in an advanced care center.
Troeltzsch M; Probst FA; Knösel T; Mast G; Ehrenfeld M; Otto S
Int J Dermatol; 2016 Nov; 55(11):1281-1288. PubMed ID: 27420481
[TBL] [Abstract][Full Text] [Related]
38. [Basalioma].
Diem E
Ther Umsch; 1993 Dec; 50(12):812-6. PubMed ID: 8171402
[TBL] [Abstract][Full Text] [Related]
39. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
40. Metastatic basal cell carcinoma: report of two cases and literature review.
Ting PT; Kasper R; Arlette JP
J Cutan Med Surg; 2005 Jan; 9(1):10-5. PubMed ID: 16208438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
